Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries

NCT: NCT04322370 · COMPLETED

NCT IDNCT04322370
StatusCOMPLETED
Start Date2020-08-21
Completion2026-03-31
SponsorUniversity of Florida (OTHER)
First posted
Last updated

Brief Summary

To analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups. The first group will be the negative control, with no tendon wrap. The second group will have a VersaWrap Tendon Protector applied over the site of the tendon repair. VersaWrap is current SOC at UF.

Frequently Asked Questions

What is Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries?

Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries is a clinical trial registered under NCT04322370. Current status: COMPLETED.

What is the status of NCT04322370?

The current status of NCT04322370 (Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries) is: COMPLETED.

When did Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries start?

Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries started on 2020-08-21.

Related Devices

K160364VersaWrap Tendon ProtectorAlafair Biosciences, Inc. K200311VersaWrap Tendon ProtectorAlafair Biosciences, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑